Efficacy and Safety of HGP1910 and HCP1903 in Patients With Primary Hypercholesterolemia
Clinical trial NCT04652349 · COMPLETED
Trial details
- NCT number
- NCT04652349
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-06
- Primary completion
- 2020-12-17
- Enrollment
- 279
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.